Mersch J, Jackson MA, Park M, Nebgen D, Peterson SK, Singletary C, Arun BK and Litton JK. Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer. 2015;121:269‐275.

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|14|2474-2475

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.14, 2015-07, pp. : 2474-2475

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian

By  

CANCER, Vol. 121, Iss. 2, 2015-01 ,pp. : 269-275

John Wiley & Sons Inc

Access to resources Recommend Favorite

Erratum: Bayraktar S, Elsayegh N, Gutierrez Barrera AM, Lin H, Kuerer H, Tasbas T, Muse KI, Ready K, Litton J, Meric‐Bernstam F, Hortobagyi GN, Albarracin CT and Arun B. Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ. Cancer. 2012;118:1515‐22.

By  

CANCER, Vol. 120, Iss. 6, 2014-03 ,pp. : 927-927

John Wiley & Sons Inc

Access to resources Recommend Favorite

BRCA1 and BRCA2 Mutations in the Ovarian Cancer Population across Race and Ethnicity: Special Reference to Asia

By  

Oncology, Vol. 84, Iss. 4, 2013-01 ,pp. : 226-232

Karger

Access to resources Recommend Favorite

The Influence of BRCA1/BRCA2 Mutations on Toxicity Related to Chemotherapy and Radiotherapy in Early Breast Cancer Patients

By  

Oncology, Vol. 85, Iss. 5, 2013-11 ,pp. : 278-282

Karger

Access to resources Recommend Favorite

Management of early-onset breast cancer and BRCA1 or BRCA2 status

By Haffty B.G.  

The Lancet, Vol. 360, Iss. 333, 2002-08 ,pp. : 640-641

Elsevier

Access to resources Recommend Favorite